Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Royal Caribbean
RCL
$78.2B
| $3.04M | 0.01% |
38,572
-67,324
| -64% | -$5.13M |
|
|
TRIL
1677
DELISTED
Trillium Therapeutics Inc.
TRIL
| $3.02M | 0.01% |
+138,453
| New | +$3.16M |
|
1678
Roper Technologies
ROP
$40.9B
| $3.01M | 0.01% |
+17,474
| New | +$3.03M |
|
|
CFNL
1679
DELISTED
Cardinal Financial Corp
CFNL
| $3.01M | 0.01% |
+138,202
| New | +$2.88M |
|
1680
CALL
NCR Voyix
VYX
$1.12B
| $3.01M | 0.01% |
+163,000
| New | +$3.01M |
|
|
UNIS
1681
DELISTED
Unilife Corporation
UNIS
| $3M | 0.01% |
139,781
+5,097
| +4% | +$155K |
|
1682
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.5B
| $3M | 0.01% |
61,750
+250
| +0.4% | +$12.1K |
|
|
BLT
1683
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
| $2.99M | 0.01% |
274,135
-15,623
| -5% | -$191K |
|
|
SUNE
1684
PUT
DELISTED
SUNEDISON, INC COM
SUNE
| $2.99M | 0.01% |
+100,000
| New | +$2.85M |
|
|
COBZ
1685
DELISTED
CoBiz Financial,Inc
COBZ
| $2.98M | 0.01% |
228,171
-104,836
| -31% | -$1.29M |
|
1686
Simpson Manufacturing
SSD
$7.65B
| $2.98M | 0.01% |
+87,675
| New | +$3.03M |
|
|
AXON
1687
Axon Enterprise
AXON
$49.8B
| $2.97M | 0.01% |
+89,157
| New | +$2.79M |
|
1688
TriplePoint Venture Growth BDC
TPVG
$217M
| $2.97M | 0.01% |
220,338
+116,511
| +112% | +$1.62M |
|
|
ZGNX
1689
DELISTED
Zogenix, Inc.
ZGNX
| $2.95M | 0.01% |
219,676
-46,778
| -18% | -$573K |
|
1690
Stride
LRN
$3.56B
| $2.94M | 0.01% |
232,697
-106,940
| -31% | -$1.59M |
|
1691
Photronics
PLAB
$1.73B
| $2.94M | 0.01% |
+309,332
| New | +$2.9M |
|
|
ENH
1692
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $2.94M | 0.01% |
44,733
+34,589
| +341% | +$2.15M |
|
|
ANH
1693
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $2.93M | 0.01% |
594,337
-616,035
| -51% | -$3.19M |
|
1694
Sensata Technologies
ST
$6.14B
| $2.93M | 0.01% |
55,536
-2,588
| -4% | -$145K |
|
1695
Hercules Capital
HTGC
$3.29B
| $2.92M | 0.01% |
+252,941
| New | +$3.29M |
|
1696
Guidewire Software
GWRE
$15.7B
| $2.91M | 0.01% |
54,910
-510,469
| -90% | -$26.3M |
|
1697
CALL
NOV
NOV
$7.11B
| $2.9M | 0.01% |
+60,000
| New | +$3.08M |
|
|
FGL
1698
DELISTED
Fidelity & Guaranty Life
FGL
| $2.9M | 0.01% |
122,524
+48,973
| +67% | +$1.1M |
|
|
NS
1699
DELISTED
NuStar Energy L.P.
NS
| $2.89M | 0.01% |
+48,750
| New | +$3.08M |
|
1700
CALL
PTC Therapeutics
PTCT
$6.13B
| $2.89M | 0.01% |
60,000
+10,000
| +20% | +$583K |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.